美股異動丨騰訊音樂(TME.US)盤前漲逾3% 四季度付費用户續創新高
格隆匯3月22日丨騰訊音樂(TME.US)盤前漲逾3%,報4.8美元。騰訊音樂發佈了截至2021年12月31日的全年未經審計財務報吿。2021年騰訊音樂總營收同比增長7.2%至312.4億元,非國際財務報吿準則下(Non-IFRS)歸屬公司股東淨利潤為41.5億元,在線音樂付費用户達到7620萬再創新高,付費率超12%。騰訊音樂娛樂集團執行董事長彭迦信表示,去年公佈的10億美元股票回購計劃已執行超50%,該計劃的剩餘部分將在2022年完成。此外,計劃在獲得監管部門批准的情況下,以介紹形式在香港聯合交易所主板二次上市。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.